Jean‐Marc Zini

1.3k total citations
33 papers, 867 citations indexed

About

Jean‐Marc Zini is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jean‐Marc Zini has authored 33 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 17 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Jean‐Marc Zini's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (6 papers). Jean‐Marc Zini is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (6 papers). Jean‐Marc Zini collaborates with scholars based in France, United States and Belgium. Jean‐Marc Zini's co-authors include G Tobelem, Évelyne Dupuy, Jean‐Marc Herbert, Bertrand Godeau, Sylvie Chevret, Stéphane Chèze, Cyrille Hulin, Marie‐José Grange, Éric Legouffe and Philippe Bierling and has published in prestigious journals such as The Lancet, Blood and Biochemical Journal.

In The Last Decade

Jean‐Marc Zini

33 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Marc Zini France 15 492 219 209 173 134 33 867
Satoru Kosugi Japan 18 727 1.5× 265 1.2× 125 0.6× 220 1.3× 133 1.0× 40 1.0k
Judith C. Andersen United States 11 443 0.9× 144 0.7× 139 0.7× 57 0.3× 152 1.1× 17 721
Grzegorz Helbig Poland 16 342 0.7× 165 0.8× 96 0.5× 99 0.6× 180 1.3× 122 857
J. Rifón Spain 18 515 1.0× 361 1.6× 253 1.2× 641 3.7× 123 0.9× 60 1.5k
David Musselman United States 9 307 0.6× 201 0.9× 116 0.6× 112 0.6× 174 1.3× 16 1.3k
Valérie Proulle France 19 606 1.2× 111 0.5× 54 0.3× 238 1.4× 88 0.7× 52 1.0k
Carlos Bidot United States 18 398 0.8× 61 0.3× 84 0.4× 320 1.8× 123 0.9× 47 965
DB Cines United States 11 1.1k 2.3× 204 0.9× 206 1.0× 83 0.5× 163 1.2× 18 1.4k
Mauricio Ocqueteau Chile 13 617 1.3× 179 0.8× 101 0.5× 352 2.0× 43 0.3× 33 933
David C. Calverley United States 13 230 0.5× 66 0.3× 66 0.3× 131 0.8× 107 0.8× 33 723

Countries citing papers authored by Jean‐Marc Zini

Since Specialization
Citations

This map shows the geographic impact of Jean‐Marc Zini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marc Zini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marc Zini more than expected).

Fields of papers citing papers by Jean‐Marc Zini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marc Zini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marc Zini. The network helps show where Jean‐Marc Zini may publish in the future.

Co-authorship network of co-authors of Jean‐Marc Zini

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marc Zini. A scholar is included among the top collaborators of Jean‐Marc Zini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marc Zini. Jean‐Marc Zini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lin‐Pierre, Nabih Maslah, Emmanuelle Verger, et al.. (2021). Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 138(21). 2142–2148. 20 indexed citations
2.
Soret, Juliette, Nicolas Gauthier, Emmanuelle Verger, et al.. (2020). SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN). Blood. 136(Supplement 1). 1–1. 2 indexed citations
3.
Soret, Juliette, Nicolas Gauthier, Emmanuelle Verger, et al.. (2020). NFE2 Mutations Impact AML Transformation and Overall Survival in Patients with Myeloproliferative Neoplasms (MPN). Blood. 136(Supplement 1). 36–36. 2 indexed citations
4.
5.
Durot, Éric, Cécile Tomowiak, Anne‐Sophie Michallet, et al.. (2016). Retrospective Analysis of 56 Cases of Transformed Waldenström Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO). Blood. 128(22). 2982–2982. 4 indexed citations
6.
Cornet, Édouard, Alain Delmer, Pierre Feugier, et al.. (2014). Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Annals of Hematology. 93(12). 1977–1983. 34 indexed citations
7.
Jaccard, Arnaud, Barbara Petit, Stéphane Girault, et al.. (2008). L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Annals of Oncology. 20(1). 110–116. 102 indexed citations
8.
Schnepf, Nathalie, et al.. (2007). Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy. Journal of Clinical Virology. 39(1). 48–50. 11 indexed citations
9.
10.
Brouland, Jean‐Philippe, et al.. (2003). Mixed Myelodysplastic Syndrome and Myeloproliferative Disorder with Bone Marrow and Pulmonary Fibrosis: The Role of Megakaryocytes. Acta Haematologica. 109(3). 145–149. 4 indexed citations
11.
12.
Dupuy, Évelyne, Claudine Soria, P Molho, et al.. (2001). Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thrombosis Research. 102(3). 211–219. 68 indexed citations
13.
Cramer, Elisabeth M., Isabel Garcı́a, Jean‐Marc Massé, et al.. (1999). Erythroblastic Synartesis: An Auto-immune Dyserythropoiesis. Blood. 94(11). 3683–3693. 7 indexed citations
14.
15.
Tournilhac, Olivier, Jean‐Jacques Kiladjian, Jean‐Michel Cayuela, et al.. (1997). Aplastic anaemia in a case of hereditary neutrophil Fcγ receptor IIIb deficiency. British Journal of Haematology. 99(2). 422–425. 2 indexed citations
16.
17.
18.
Duet, M., et al.. (1995). Indium-111 pentetreotide scintigraphy in malignant lymphomas. European Journal of Nuclear Medicine and Molecular Imaging. 22(10). 1105–1109. 15 indexed citations
19.
Bellucci, Sylvia, Jean‐Marc Zini, Pierre Bitoun, et al.. (1995). Diffuse Severe Digestive Angiodysplasia in Bernard-Soulier Syndrome. Thrombosis and Haemostasis. 74(6). 1610–1612. 11 indexed citations
20.
Zini, Jean‐Marc. (1995). Physiopathology of thrombosis induced by antiphospholipid antibodies. Clinical Reviews in Allergy & Immunology. 13(1). 5–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoru Kosugi Breakdown of academic impact, for papers by Judith C. Andersen Breakdown of academic impact, for papers by Grzegorz Helbig Breakdown of academic impact, for papers by J. Rifón Breakdown of academic impact, for papers by David Musselman Breakdown of academic impact, for papers by Valérie Proulle Breakdown of academic impact, for papers by Carlos Bidot Breakdown of academic impact, for papers by DB Cines Breakdown of academic impact, for papers by Mauricio Ocqueteau Breakdown of academic impact, for papers by David C. Calverley
Rankless by CCL
2026